Preliminary safety evaluation of the putative cancer chemopreventive agent tricin, a naturally occurring flavone Richard D. VerschoylePeter GreavesAndreas J. Gescher Original Article 07 July 2005 Pages: 1 - 6
Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes Ann M. StraightKevin OakleyGary L. Francis Original Article 05 July 2005 Pages: 7 - 14
Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumors Carlos Rodriguez-GalindoKristine R. CrewsVictor M. Santana Original Article 07 July 2005 Pages: 15 - 24
GBP1 overexpression is associated with a paclitaxel resistance phenotype Zhenfeng DuanRosemary FosterMichael V. Seiden Original Article 19 July 2005 Pages: 25 - 33
Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours Michele CaragliaRaffaele AddeoSalvatore Del Prete Original Article 12 July 2005 Pages: 34 - 39
Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy David A. BellnierWilliam R. GrecoThomas J. Dougherty Original Article 05 July 2005 Pages: 40 - 45
Weekly docetaxel and zoledronic acid every 4 weeks in hormone-refractory prostate cancer patients Gianfilippo BertelliAbdelhamid HeouaineMarco Merlano Original Article 07 July 2005 Pages: 46 - 51
Factors determining the optimal body site and method for obtaining punch biopsies of human skin as a tissue in which to assess pharmacodynamic and pharmacokinetic endpoints in drug development studies D. R. CamidgeM. J. DaviesA. M. Hughes Original Article 20 July 2005 Pages: 52 - 58
Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study Alessandra FeliciPaolo CarliniFrancesco Cognetti Original Article 05 July 2005 Pages: 59 - 64
Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo V. KirvelieneG. GrazelieneJ. Didziapetriene Original Article 05 July 2005 Pages: 65 - 72
Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia Hans MindermanKieran L. O’LoughlinMaria R. Baer Original Article 12 July 2005 Pages: 73 - 83
Role of Na+, K+-ATPase α1 subunit in the intracellular accumulation of cisplatin Shuichi KishimotoYuji KawazoeYoshikazu Takeuchi Original Article 26 July 2005 Pages: 84 - 90
Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer Se Hoon ParkJeeyun LeeJae Hoon Lee Original Article 09 August 2005 Pages: 91 - 96
Study on brain targeting of raltitrexed following intranasal administration in rats Dongxing WangYongliang GaoLiuhong Yun Original Article 19 July 2005 Pages: 97 - 104
Cyclopentenyl cytosine-induced activation of deoxycytidine kinase increases gemcitabine anabolism and cytotoxicity in neuroblastoma Jörgen BierauAlbert H. van GennipAndré B. P. van Kuilenburg Original Article 25 August 2005 Pages: 105 - 113
Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer Baoli QinKen KatoShuji Nakano Clinical Trial Report 05 July 2005 Pages: 114 - 119
Role of plasma lipids and lipoproteins in predicting amphotericin B-induced nephrotoxicity in pediatric oncology patients Kishor M. WasanJoyce C. WongSheila Pritchard Short Communication 11 August 2005 Pages: 120 - 124
Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone Seppo W. LangerAnnemette V. ThougaardPeter Buhl Jensen Short Communication 05 July 2005 Pages: 125 - 128
Characterization of secretory intestinal transport of the lactone form of CPT-11 Isao TakemotoShirou ItagakiKen Iseki Short Communication 08 July 2005 Pages: 129 - 133
